Future alternative therapies in the pipeline for mild neonatal encephalopathy: Review of evidence of neuroprotection with erythropoiesis stimulating agents

DuPont Tara; Chalak Lina

首页> 外文期刊>Early human development >Future alternative therapies in the pipeline for mild neonatal encephalopathy: Review of evidence of neuroprotection with erythropoiesis stimulating agents

【24h】

Future alternative therapies in the pipeline for mild neonatal encephalopathy: Review of evidence of neuroprotection with erythropoiesis stimulating agents

机译：用于温和新生儿脑病的前途替代疗法：综述红细胞发育刺激剂神经保护症的证据

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Early human development》 |2018年第2018期|共4页
作者
DuPont Tara; Chalak Lina;
展开▼
作者单位

Univ New Mexico Sch Med Dept Pediat Div Neonatol Albuquerque NM 87131 USA;

Univ New Mexico Sch Med Dept Pediat Div Neonatol Albuquerque NM 87131 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Future alternative therapies in the pipeline for mild neonatal encephalopathy: Review of evidence of neuroprotection with erythropoiesis stimulating agents [J] . DuPont Tara, Chalak Lina Early human development . 2018,第期

机译：用于温和新生儿脑病的前途替代疗法：综述红细胞发育刺激剂神经保护症的证据
2. A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia [J] . Arantes Luiz H. Jr., Crawford Jeffrey, Gascon Pere, Critical reviews in oncology/hematology . 2018,第期

机译：在治疗化疗诱导的贫血和慢性肾病贫血中，快速划分的疗效，安全，经济和健康相关质量结果，致力于和长期的促红细胞生成刺激剂和慢性肾病血症
3. Dose efficiency of Erythropoiesis-Stimulating agents for the treatment of patients with chemotherapy-induced anemia: A systematic review [J] . ForbesC.A., WorthyG., HarkerJ., Clinical therapeutics . 2014,第4期

机译：促红细胞生成素治疗化疗性贫血患者的剂量效率：系统评价
4. Equine Neonatal Maladjustment Syndrome/Neonatal Encephalopathy: Evidence for the Etiology and Treatment [C] . American College of Veterinary Internal Medicine Forum Conference . 2019

机译：马上新生儿患有综合征/新生儿脑病：病因和治疗的证据
5. Impact of Erythropoiesis Stimulating Agents on Survival and Risk of Venous Thromboembolism Among Patients with Colorectal Cancer Receiving Chemotherapy. [D] . Sato, Masayo. 2012

机译：红细胞生成刺激剂对接受化疗的结直肠癌患者生存率和静脉血栓栓塞风险的影响。
6. Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promiseas Neuroprotective Agents in Neonates [O] . Robin K. Ohls, Robert D. Christensen, John A. Widness, -1

机译：红细胞生成刺激剂显示安全性并显示出承诺在新生儿中作为神经保护剂
7. MO556TREATMENT OF ANAEMIA WITH ERYTHROPOIESIS STIMULATION AGENTS (ESAS) AND CONCOMITANT THERAPIES AMONG PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) IN GERMANY, SPAIN AND THE UK: A RETROSPECTIVE CHART REVIEW [O] . Danilo Fliser, Jose Portoles, Katherine Houghton, 2021

机译：患有促红细胞血液刺激剂（ESAs）的贫血患者的MO556治疗，伴随着德国，西班牙和英国的非透析依赖性慢性肾病（NDD-CKD）的患者伴随疗法：回顾性图表审查

Future alternative therapies in the pipeline for mild neonatal encephalopathy: Review of evidence of neuroprotection with erythropoiesis stimulating agents

著录项

相似文献

相关主题

期刊订阅